(Q46745755)

English

A retrospective randomly selected cohort study of D-penicillamine treatment in rapidly progressive diffuse cutaneous systemic sclerosis of recent onset.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284395

A retrospective randomly selected cohort study of D-penicillamine treatment in rapidly progressive diffuse cutaneous systemic sclerosis of recent onset (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6744940&resulttype=core&format=json

12 May 2020

D-penicillamine

1 reference

based on heuristic

inferred from title

Sergio A Jimenez

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6744940&resulttype=core&format=json

12 May 2020

author name string

C T Derk

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6744940&resulttype=core&format=json

12 May 2020

G Huaman

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6744940&resulttype=core&format=json

12 May 2020

language of work or name

0 references

publication date

16 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284395

British Journal of Dermatology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6744940&resulttype=core&format=json

12 May 2020

158

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6744940&resulttype=core&format=json

12 May 2020

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6744940&resulttype=core&format=json

12 May 2020

1063-1068

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6744940&resulttype=core&format=json

12 May 2020

Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08452.X

21 January 2018

D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08452.X

21 January 2018

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08452.X

21 January 2018

Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08452.X

21 January 2018

Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08452.X

21 January 2018

Biosynthesis and maturation of skin collagen in scleroderma, and effect of D-penicillamine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08452.X

21 January 2018

D-penicillamine in systemic sclerosis? Yes!

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08452.X

21 January 2018

Improvement in skin thickening in systemic sclerosis associated with improved survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08452.X

21 January 2018

Reliability of skin involvement measures in scleroderma. The UK Scleroderma Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08452.X

21 January 2018

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08452.X

21 January 2018

Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A disease severity scale for systemic sclerosis: development and testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bosentan therapy for pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of disease severity and prognosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Burn size estimate reliability: a study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ketanserin in the treatment of systemic sclerosis: a double-blind controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of penicillamine on human collagen and its possible application to treatment of scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Collagen Defect induced by Penicillamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D-penicillamine in progressive scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of penicillamine on new and pre-existing (3H) collagen in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skin collagen in patients with scleroderma: biosynthesis and maturation in vitro, and the effect of D-penicillamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A defect in the intramolecular and intermolecular cross-linking of collagen caused by penicillamine. I. Metabolic and functional abnormalities in soft tissues.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Collagen Defect Induced by Penicillamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Penicillamine-induced immunosuppression: in vitro studies of inhibition of immunoglobulin synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Captopril in the treatment of scleroderma renal crisis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progressive systemic sclerosis and penicillamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical course of patients with scleroderma renal crisis treated with captopril

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18284395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2133.2008.08452.X

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6744940&resulttype=core&format=json

12 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6744940&resulttype=core&format=json

12 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6744940&resulttype=core&format=json

12 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46745755&oldid=1585759078"